Ledger.Open graph →
SEC Form D · filed May 18, 2016

DEXCOM INC

Offering
$7.2M
Sold
$7.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (32)

Jay S. Skyler · San Diego, CADirectorEric T. Topol · San Diego, CADirectorSteven R. Pacelli · San Diego, CAExecNicholas H. Augustinos · San Diego, CADirectorSteven R. Altman · San Diego, CADirectorMark S. Foletta · San Diego, CADirectorRichard K. Doubleday · San Diego, CAExecBarbara E. Kahn · San Diego, CADirectorJonathan T. Lord · South San Francisco, CADirectorJeffrey D. Moy · San Diego, CAExecTerrance H. Gregg · San Diego, CAExec · DirectorJorge R. Valdes · San Diego, CAExecJohn D. Lister · San Diego, CAExecJess R. Roper · San Diego, CAExecAndrew K. Balo · San Diego, CAExecKevin Sayer · San Diego, CAExec · DirectorJay S. Skyler · San Diego, CADirectorRichard K. Doubleday · San Diego, CAExecEric T. Topol · San Diego, CADirectorBarbara E. Kahn · San Diego, CADirectorSteven R. Pacelli · San Diego, CAExecJonathan T. Lord · Miami, FLDirectorJeffrey D. Moy · San Diego, CAExecNicholas H. Augustinos · San Diego, CADirectorTerrance H. Gregg · San Diego, CAExec · DirectorJorge R. Valdes · San Diego, CAExecJohn D. Lister · San Diego, CAExecJess R. Roper · San Diego, CAExecAndrew K. Balo · San Diego, CAExecKevin Sayer · San Diego, CAExec · DirectorSteven R. Altman · San Diego, CADirectorMark S. Foletta · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗